跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,116 条关于
“Alder Biopharmaceuticals”
全部
6,116
临床试验
5,376
药物
191
机构
99
资讯
450
9年前
Alder BioPharmaceuticals Announces Positive Eptinezumab Phase 3 Results for Migraine Prevention
8年前
Alder BioPharmaceuticals to Present New Phase 3 Migraine Prevention Data for Eptinezumab
8年前
Alder BioPharmaceuticals to Showcase Eptinezumab's Efficacy in Migraine Prevention at AHS Meeting
7年前
Alder BioPharmaceuticals Presents New Data on Eptinezumab's Clinical Profile for Migraine Prevention
3个月前
Vedana Therapeutics Launches with $46M Series A to Develop Next-Generation PACAP-Targeting Migraine Therapies
6个月前
Slate Medicines Raises $130M to Develop Novel PACAP-Targeting Migraine Drug
6个月前
Slate Medicines Secures $130M Series A to Advance Novel Anti-PACAP Migraine Therapy
去年
Zentalis Pharmaceuticals Appoints James B. Bucher as Chief Legal Officer to Support Azenosertib's Advancement
4个月前
Mentari Therapeutics Goes Public Through $421M Reverse Merger to Advance Novel PACAP-Targeting Migraine Therapies
去年
pGTI Applied in STAR-JIA Trial to Assess Steroid Toxicity in Children with Juvenile Idiopathic Arthritis
第 1 页,共 45 页
上一页
下一页